Home

Deserto felicità Festa c myc inhibitors clinical trials Giorno giocare design

Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin  sensitivity in ER‑positive breast cancer
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer

Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital  Age: Trends in Pharmacological Sciences
Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age: Trends in Pharmacological Sciences

Alternative approaches to target Myc for cancer treatment | Signal  Transduction and Targeted Therapy
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

MYC inhibitors in multiple myeloma
MYC inhibitors in multiple myeloma

Taking the Myc out of cancer: toward therapeutic strategies to directly  inhibit c-Myc | Molecular Cancer | Full Text
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text

Alternative approaches to target Myc for cancer treatment | Signal  Transduction and Targeted Therapy
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy

A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization  and induces apoptosis in cancer cells - Journal of Biological Chemistry
A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells - Journal of Biological Chemistry

Targeting oncogenic Myc as a strategy for cancer treatment | Signal  Transduction and Targeted Therapy
Targeting oncogenic Myc as a strategy for cancer treatment | Signal Transduction and Targeted Therapy

Taking the Myc out of cancer: toward therapeutic strategies to directly  inhibit c-Myc | Molecular Cancer | Full Text
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text

Taking the Myc out of cancer: toward therapeutic strategies to directly  inhibit c-Myc | Molecular Cancer | Full Text
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text

Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based |  DDDT
Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based | DDDT

MYC inhibitors in multiple myeloma
MYC inhibitors in multiple myeloma

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

Targeting MYC: From understanding its biology to drug discovery -  ScienceDirect
Targeting MYC: From understanding its biology to drug discovery - ScienceDirect

A role for c-Myc as a key signaling node. The expression of... | Download  Scientific Diagram
A role for c-Myc as a key signaling node. The expression of... | Download Scientific Diagram

Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability |  Cell and Developmental Biology
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology

Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and  preserves Antitumor Macrophages in Breast Cancer
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer

c-Myc Metabolic Addiction in Cancers Counteracted by Resveratrol and NQO2 |  IntechOpen
c-Myc Metabolic Addiction in Cancers Counteracted by Resveratrol and NQO2 | IntechOpen

Mission Possible: Advances in MYC Therapeutic Targeting in Cancer |  SpringerLink
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer | SpringerLink

Inhibition of cIAP1 as a strategy for targeting c-MYC–driven oncogenic  activity | PNAS
Inhibition of cIAP1 as a strategy for targeting c-MYC–driven oncogenic activity | PNAS

Therapeutic targeting of “undruggable” MYC - eBioMedicine
Therapeutic targeting of “undruggable” MYC - eBioMedicine

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

Reproducibility in Cancer Biology: Small molecules remain on target for c- Myc | eLife
Reproducibility in Cancer Biology: Small molecules remain on target for c- Myc | eLife

Small-molecule inhibitors of c-Myc transcriptional factor suppress  proliferation and induce apoptosis of promyelocytic leukemia cell via cell  cycle arrest - Molecular BioSystems (RSC Publishing)
Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest - Molecular BioSystems (RSC Publishing)